Conference Proceedings

Phase I clinical trial of gemcitabine (GEM) in combination with PF-00477736 (PF-736), a selective inhibitor of CHK1 kinase

N Brega, GA McArthur, C Britten, SG Wong, E Wang, KD Wilner, A Blasina, GK Schwartz, J Gallo, AN Tse

JOURNAL OF CLINICAL ONCOLOGY | AMER SOC CLINICAL ONCOLOGY | Published : 2010